Pressure BioSciences
Pressure Biosciences, Leica Enter Comarketing Deal for Mass Spec Sample Prep
The platform combines Leica's laser microdissection tool and PBI's pressure cycling tech to enable better extraction and digestion of proteins from biopsies.
Pressure BioSciences Q2 Revenues Up 6 Percent
The company also disclosed that it dropped plans for a $12.5 million offering of stock and warrants following a recent reverse stock split.
Pressure Biosciences Plans Reverse Stock Split
The one-for-30 reverse split is intended to increase the price of the company's stock, enabling it to satisfy the Nasdaq's initial listing requirements.
Pressure Bio Posts 8 Percent Revenue Growth in Q1
The revenue increase was driven by growth in sales of both instrument systems and consumables.
Pressure Biosciences Q4 Revenues Up 15 Percent
A 55 percent increase in the company's Q4 products and services revenues was softened by a 58 percent decrease in its grant revenues.
Nov 16, 2016
Pressure Biosciences Q3 Revenues Fall 8 Percent
Aug 16, 2016
Pressure Biosciences Q2 Revenues Up 24 Percent
May 18, 2016
Pressure Biosciences Q1 Revenues Increase 16 Percent
May 6, 2016
Apr 6, 2016
Pressure Bio FY 2015 Revenues Up 31 Percent
Jan 12, 2016
Sciex and Pressure Biosciences Ink Comarketing Deal
Nov 12, 2015
Pressure Bio's Q3 Revenues Climb 56 Percent
Apr 1, 2015